Medicare Enrolled

Dr. Wasim Deeb, M.D.

Endocrinology · Jacksonville, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
8837 GOODBYS EXECUTIVE DR, Jacksonville, FL 32217
9049900555
In practice since 2006 (19 years)
NPI: 1881700698 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Deeb from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Deeb? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Deeb

Dr. Wasim Deeb is an endocrinology in Jacksonville, FL, with 19 years in practice. Based on federal Medicare data, Dr. Deeb performed 14,996 Medicare services across 2,070 unique beneficiaries.

Between the years covered by Open Payments, Dr. Deeb received a total of $302,556 from 78 pharmaceutical and/or device companies across 2180 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Deeb is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 5% volume in FL$ $302,556 industry payments

Medicare Practice Summary

Medicare Utilization ↗
14,996
Medicare services
Top 5% in FL for endocrinology
2,070
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~789 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)11,460$18$25
Office visit, established patient (30-39 min)1,430$86$197
Drug injection, under skin or into muscle660$10$30
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg429$1$15
Hemoglobin A1c test (diabetes monitoring)280$9$20
Office visit, established patient, complex (40-54 min)202$135$264
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report189$25$65
Blood glucose (sugar) test performed by hand-held instrument162$3$10
New patient office visit (45-59 min)104$120$300
New patient office visit, complex (60-74 min)40$154$377
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment14$101$265
Fine needle aspiration biopsy using ultrasound guidance, first growth13$106$231
Ultrasonic guidance for needle placement13$45$188
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$302,556
Total received (2018-2024)
Avg $43,222/year across 7 years
Top 4% in FL for endocrinology
78
Companies
2,180
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$273,179 (90.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,165 (7.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,213 (2.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$26,773
2023
$19,314
2022
$56,055
2021
$58,318
2020
$17,122
2019
$70,033
2018
$54,941

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$92,402
Novo Nordisk Inc
$84,900
AstraZeneca Pharmaceuticals LP
$58,688
Janssen Pharmaceuticals, Inc
$17,048
Insulet Corporation
$8,813
Merck Sharp & Dohme Corporation
$8,121
SANOFI-AVENTIS U.S. LLC
$6,783
VIVUS, Inc.
$6,762
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,537
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,349
Lilly USA, LLC
$1,206
Abbott Laboratories
$1,108
Amneal Pharmaceuticals LLC
$1,057
Dexcom, Inc.
$1,007
Xeris Pharmaceuticals, Inc.
$889
Amarin Pharma Inc.
$781
MannKind Corporation
$712
Corcept Therapeutics
$652
Mannkind Corporation
$606
Endo Pharmaceuticals Inc.
$591
Radius Health, Inc.
$561
Antares Pharma, Inc.
$555
Bayer Healthcare Pharmaceuticals Inc.
$475
Tandem Diabetes Care, Inc.
$466
Medtronic, Inc.
$376
IBSA Pharma Inc.
$350
Bayer HealthCare Pharmaceuticals Inc.
$290
CeQur Corporation
$268
Valeritas, Inc.
$250
Currax Pharmaceuticals LLC
$230
Novartis Pharmaceuticals Corporation
$219
Clarus Therapeutics Inc.
$210
Zealand Pharma US, Inc.
$207
AbbVie Inc.
$205
Alexion Pharmaceuticals, Inc.
$195
Kowa Pharmaceuticals America, Inc.
$190
ABBVIE INC.
$187
Bausch Health US, LLC
$178
Merck Sharp & Dohme LLC
$168
Horizon Therapeutics plc
$154
AbbVie, Inc.
$142
Medtronic MiniMed, Inc.
$131
DEXCOM, INC.
$121
OPKO Pharmaceuticals, LLC
$102
BETA BIONICS, INC.
$95
Avvisto Therapeutics, LLC
$90
Ascensia Diabetes Care Us Inc.
$87
KVK-Tech, Inc.
$82
Supernus Pharmaceuticals, Inc.
$72
Acerus Pharmaceuticals Corporation
$72
Madrigal Pharmaceuticals
$57
Companion Medical, Inc.
$55
Relypsa, Inc.
$52
Ipsen Biopharmaceuticals, Inc
$49
Embecta Corp.
$47
ARBOR PHARMACEUTICALS, INC.
$44
Shire North American Group Inc
$43
VIVUS LLC
$38
Upsher-Smith Laboratories LLC
$37
LifeScan, Inc.
$36
Nalpropion Pharmaceuticals LLC
$35
Arbor Pharmaceuticals, Inc.
$34
Kyowa Kirin, Inc.
$33
Aytu BioScience, Inc
$31
Orexigen Therapeutics, Inc.
$28
Esperion Therapeutics, Inc.
$23
RECORDATI_RARE_DISEASES_INC.
$18
Ferring Pharmaceuticals Inc.
$16
Strongbridge US INC.
$16
Apollo Endosurgery US Inc
$16
Senseonics, Incorporated
$15
Bigfoot Biomedical Inc
$14
SCYNEXIS, Inc.
$14
Paratek Pharmaceuticals, Inc.
$14
Intercept Pharmaceuticals, Inc.
$13
Becton, Dickinson and Company
$13
Smith+Nephew, Inc.
$13
EISAI INC.
$12
Top 3 companies account for 78.0% of total payments
Associated products mentioned in payments ›
AFREZZA · APLENZIN · AVEED · Aimovig · Androgel · BAQSIMI · BD Nano · BD Nano 2nd Gen Pen Needle · BYDUREON · Belviq · COLLAGENASE SANTYL · CONTRAVE · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EDEX · EMGALITY · ENTRESTO · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · Edarbi · Edarbyclor · Eversense · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN U · Horizant · INTELLIS ADAPTIVESTIM · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LOKELMA · LYUMJEV · Levemir · Livalo · MACRILEN · MINIMED 770G · MINIMED 780G · MOUNJARO · Minimed 670G System · NASCOBAL · NATPARA · NEXLETOL · NOCDURNA · NUZYRA · Natesto · Norditropin · OCALIVA · OT Verio Flex Starter Kit · OTREXUP · Omnipod · OneTouch Verio Reflect · Orbera · Otezla · Otrexup · Ozempic · PROCLAIM · Prolia · QSYMIA · QUDEXY XR Topiramate Extended Release Capsules · Qsymia · RAYALDEE · RECORLEV · RESMETIROM · RYBELSUS · Rayaldee · Rayaldee (old) · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · STEGLATRO · STEGLUJAN · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Synthroid · TEPEZZA · TESTOPEL · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UBRELVY · UNITHROID · UNITY DIABETES MANAGEMENT SYSTEM · V-GO · Vascepa · Veltassa · Victoza · WELLBUTRIN · WELLBUTRIN XL · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZOMACTON · iLet Bionic Pancreas · iPro2 · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for endocrinology in FL.

Equivalent to $2,018 per 100 Medicare services performed
Looking for a endocrinology in Jacksonville?
Compare endocrinologys in the Jacksonville area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
37
Per 100K population
3.7
County median income
$68,447
Nearest hospital
NH Jacksonville
4.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Deeb is a mixed practice specialist, with above-average Medicare volume (top 5% in FL), and high industry engagement (speaking/promotional, top 4%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Deeb experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Deeb performed 11,460 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Deeb receive payments from pharmaceutical companies?
Yes. Dr. Deeb received a total of $302,556 from 78 companies across 2,180 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Deeb's costs compare to other endocrinologys in Jacksonville?
Dr. Deeb's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Deeb) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →